These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 34074263)

  • 1. Randomized test-treatment studies with an outlook on adaptive designs.
    Hot A; Bossuyt PM; Gerke O; Wahl S; Vach W; Zapf A
    BMC Med Res Methodol; 2021 Jun; 21(1):110. PubMed ID: 34074263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sample size recalculation based on the prevalence in a randomized test-treatment study.
    Hot A; Benda N; Bossuyt PM; Gerke O; Vach W; Zapf A
    BMC Med Res Methodol; 2022 Jul; 22(1):205. PubMed ID: 35879675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blinded sample size re-estimation in a comparative diagnostic accuracy study.
    Stark M; Hesse M; Brannath W; Zapf A
    BMC Med Res Methodol; 2022 Apr; 22(1):115. PubMed ID: 35439947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adaptive trial designs in diagnostic accuracy research.
    Zapf A; Stark M; Gerke O; Ehret C; Benda N; Bossuyt P; Deeks J; Reitsma J; Alonzo T; Friede T
    Stat Med; 2020 Feb; 39(5):591-601. PubMed ID: 31773788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A post hoc evaluation of a sample size re-estimation in the Secondary Prevention of Small Subcortical Strokes study.
    McClure LA; Szychowski JM; Benavente O; Hart RG; Coffey CS
    Clin Trials; 2016 Oct; 13(5):537-44. PubMed ID: 27094488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sample size calculation and re-estimation based on the prevalence in a single-arm confirmatory diagnostic accuracy study.
    Stark M; Zapf A
    Stat Methods Med Res; 2020 Oct; 29(10):2958-2971. PubMed ID: 32299298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blinded and unblinded internal pilot study designs for clinical trials with count data.
    Schneider S; Schmidli H; Friede T
    Biom J; 2013 Jul; 55(4):617-33. PubMed ID: 23703749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adaptive clinical trials: progress and challenges.
    Coffey CS; Kairalla JA
    Drugs R D; 2008; 9(4):229-42. PubMed ID: 18588354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sample Size Calculation: Inaccurate A Priori Assumptions for Nuisance Parameters Can Greatly Affect the Power of a Randomized Controlled Trial.
    Tavernier E; Giraudeau B
    PLoS One; 2015; 10(7):e0132578. PubMed ID: 26173007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Some challenges with statistical inference in adaptive designs.
    Hung HM; Wang SJ; Yang P
    J Biopharm Stat; 2014; 24(5):1059-72. PubMed ID: 24915027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal flexible sample size design with robust power.
    Zhang L; Cui L; Yang B
    Stat Med; 2016 Aug; 35(19):3385-96. PubMed ID: 26999385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimized adaptive enrichment designs for three-arm trials: learning which subpopulations benefit from different treatments.
    Steingrimsson JA; Betz J; Qian T; Rosenblum M
    Biostatistics; 2021 Apr; 22(2):283-297. PubMed ID: 31420983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sample size calculations for group randomized trials with unequal group sizes through Monte Carlo simulations.
    Shi Y; Lee JH
    Stat Methods Med Res; 2018 Sep; 27(9):2569-2580. PubMed ID: 30103663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sample size determination for a binary response in a superiority clinical trial using a hybrid classical and Bayesian procedure.
    Ciarleglio MM; Arendt CD
    Trials; 2017 Feb; 18(1):83. PubMed ID: 28231813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the efficiency of adaptive sample size design.
    Cui L; Zhang L
    Stat Med; 2019 Mar; 38(6):933-944. PubMed ID: 30450621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An evaluation of inferential procedures for adaptive clinical trial designs with pre-specified rules for modifying the sample size.
    Levin GP; Emerson SC; Emerson SS
    Biometrics; 2014 Sep; 70(3):556-67. PubMed ID: 24766094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sample size adjustment designs with time-to-event outcomes: A caution.
    Freidlin B; Korn EL
    Clin Trials; 2017 Dec; 14(6):597-604. PubMed ID: 28795844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paradigms for adaptive statistical information designs: practical experiences and strategies.
    Wang SJ; Hung HM; O'Neill R
    Stat Med; 2012 Nov; 31(25):3011-23. PubMed ID: 22927234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An objective re-evaluation of adaptive sample size re-estimation: commentary on 'Twenty-five years of confirmatory adaptive designs'.
    Mehta C; Liu L
    Stat Med; 2016 Feb; 35(3):350-8. PubMed ID: 26757953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determining optimal sample sizes for multistage adaptive randomized clinical trials from an industry perspective using value of information methods.
    Chen MH; Willan AR
    Clin Trials; 2013 Feb; 10(1):54-62. PubMed ID: 23263520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.